USA - NASDAQ:RKDA - US0390143032 - Common Stock
The current stock price of RKDA is 3.665 USD. In the past month the price decreased by -16.32%. In the past year, price increased by 25.09%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ADM | ARCHER-DANIELS-MIDLAND CO | 15.76 | 29.23B | ||
BG | BUNGE GLOBAL SA | 10.6 | 15.98B | ||
INGR | INGREDION INC | 10.77 | 7.96B | ||
DAR | DARLING INGREDIENTS INC | 47.72 | 5.13B | ||
FDP | FRESH DEL MONTE PRODUCE INC | 12.55 | 1.74B | ||
CRESY | CRESUD S.A.-SPONS ADR | N/A | 530.50M | ||
LND | BRASILAGRO-CIA BRA - SPN ADR | 14.3 | 384.52M | ||
CHSCP | CHS INC - CHSINC 8 PERP | N/A | 365.65M | ||
CHSCO | CHS INC - CHSINC 7 7/8 PERP | N/A | 327.39M | ||
CHSCL | CHS INC - CHSINC 7 1/2 PERP | N/A | 316.32M | ||
CHSCN | CHS INC - CHSINC 7.1 PERP | N/A | 308.96M | ||
CHSCM | CHS INC - CHSINC 6 3/4 PERP | N/A | 307.12M |
Arcadia Biosciences, Inc. is an agricultural biotechnology company, which engages in the development of agricultural products. The company is headquartered in Davis, California and currently employs 9 full-time employees. The company went IPO on 2015-05-15. The Company’s product portfolio includes Zola Coconut Water (Zola) and Agronomic Wheat Traits. Zola is a natural, 100% coconut water. Zola is a non-genetically modified organisms (non-GMO) project verified and only contains 60 calories per serving. Zola flavors include original, original with pulp, espresso, lime and pineapple. The recipe with Zola includes smoothies, desserts, cocktails and mocktails, and bowls. The company has developed a portfolio of non-GMO specialty wheat traits to offer healthier, nutrient-rich wheat options while providing the same baking quality, taste, and texture as traditional wheat. Its non-GMO Reduced Gluten High Fiber Wheat has fewer allergenic glutens and higher fiber than traditional wheat, while its non-GMO Extended Shelf-Life Wheat extends the shelf life of milled whole wheat flour.
ARCADIA BIOSCIENCES INC
202 Cousteau Place, Suite 105
Davis CALIFORNIA 85018 US
CEO: Matthew T. Plavan
Employees: 9
Phone: 15307567077
The current stock price of RKDA is 3.665 USD. The price increased by 4.56% in the last trading session.
The exchange symbol of ARCADIA BIOSCIENCES INC is RKDA and it is listed on the Nasdaq exchange.
RKDA stock is listed on the Nasdaq exchange.
7 analysts have analysed RKDA and the average price target is 12.24 USD. This implies a price increase of 233.97% is expected in the next year compared to the current price of 3.665. Check the ARCADIA BIOSCIENCES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ARCADIA BIOSCIENCES INC (RKDA) has a market capitalization of 5.02M USD. This makes RKDA a Nano Cap stock.
ARCADIA BIOSCIENCES INC (RKDA) currently has 9 employees.
ARCADIA BIOSCIENCES INC (RKDA) has a support level at 3.15 and a resistance level at 4.39. Check the full technical report for a detailed analysis of RKDA support and resistance levels.
The Revenue of ARCADIA BIOSCIENCES INC (RKDA) is expected to grow by 20% in the next year. Check the estimates tab for more information on the RKDA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
RKDA does not pay a dividend.
ARCADIA BIOSCIENCES INC (RKDA) will report earnings on 2025-11-10, after the market close.
ARCADIA BIOSCIENCES INC (RKDA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.25).
The outstanding short interest for ARCADIA BIOSCIENCES INC (RKDA) is 0.79% of its float. Check the ownership tab for more information on the RKDA short interest.
ChartMill assigns a technical rating of 1 / 10 to RKDA. When comparing the yearly performance of all stocks, RKDA turns out to be only a medium performer in the overall market: it outperformed 44.14% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to RKDA. No worries on liquidiy or solvency for RKDA as it has an excellent financial health rating, but there are worries on the profitability.
Over the last trailing twelve months RKDA reported a non-GAAP Earnings per Share(EPS) of -2.25. The EPS increased by 54.64% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -96.75% | ||
ROE | -166.23% | ||
Debt/Equity | 0 |
7 analysts have analysed RKDA and the average price target is 12.24 USD. This implies a price increase of 233.97% is expected in the next year compared to the current price of 3.665.
For the next year, analysts expect an EPS growth of 98.82% and a revenue growth 20% for RKDA